Epcoritamab plus R-CHOP achieve high response rates in untreated high-risk DLBCL
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.